| T7369L |
Gemigliptin Tartrate(911637-19-9 free base)
|
1374639-74-3
|
98%
|
|
|
Gemigliptin Tartrate (LC15-0444 tartrate) is a highly selective, reversible and competitive inhibitor of dipeptidyl peptidase-4 (DPP-4). It has an IC50 of 10.3 n...
|
| T2401 |
Alogliptin Benzoate
|
850649-62-6
|
98%
|
|
|
Alogliptin Benzoate (SYR 322)(SYR 322), an effective and specific DPP-4 inhibitor (IC50<10 nM), exhibits greater than 10, 000-fold selectivity over DPP-8/9. Alog...
|
| T1366 |
3-Pyridylacetic acid hydrochloride
|
6419-36-9
|
|
|
|
3-Pyridylacetic acid hydrochloride (3-PAA-HCl) is a high homologue of niacin. It is a decomposition product of nicotine (and other tobacco alkaloids). It can als...
|
| T7133 |
Anagliptin
|
739366-20-2
|
100%
|
|
|
Anagliptin (SK-0403) is a potent Inhibitor of DPP-4(IC50 of 3.8 nM), for the treatment of type 2 diabetes mellitus.
|
| T6999 |
Teneligliptin hydrobromide
|
906093-29-6
|
100%
|
|
|
Teneligliptin hydrobromide (MP-513 (hydrobromide)) is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, r...
|
| T29019 |
TS-021
|
667865-69-2
|
100%
|
|
|
TS-021 is a selective dipeptidyl peptidase 4 (DPP-4) inhibitor with antidiabetic activity for the study of type 2 diabetes.
|
| T2296 |
Trelagliptin succinate
|
1029877-94-8
|
100%
|
|
|
Trelagliptin succinate (SYR-472 succinate) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2...
|
| T7369 |
Gemigliptin
|
911637-19-9
|
98%
|
|
|
Gemigliptin (LC15-0444) is a potent dipeptidyl peptidase-4 (DPP-4) inhibitor(KD : 7.25 nM.)
|
| T1502 |
Vildagliptin
|
274901-16-5
|
98%
|
|
|
Vildagliptin (LAF237) is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cy...
|
| TN1418 |
Azaleatin
|
529-51-1
|
98.62%
|
|
|
Azaleatin is a natural product from Rhododendron simsii. Azaleatin is a dipeptidyl peptidase-IV inhibitor. Azaleatin can be used for type-2 diabetes and obesity ...
|
| T11526 |
DPP-IV-IN-2
|
136259-18-2
|
98.93%
|
|
|
DPP-IV-IN-2 (H-Lys(4-nitro-Z)-pyrrolidide) is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (IC50s: 0.1 and 0.95 μM).
|
| T6237 |
Trelagliptin
|
865759-25-7
|
98.94%
|
|
|
Trelagliptin (SYR-472) is a highly specific and long-acting DPP-4 inhibitor.
|
| T12710 |
Retagliptin Phosphate
|
1256756-88-3
|
98.97%
|
|
|
Retagliptin Phosphate (SP 2086) is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
|
| T25340 |
Diprotin A
|
90614-48-5
|
99.29%
|
|
|
Diprotin A (Ile-Pro-Ile) (Ile-Pro-Ile) is a dipeptidyl peptidase IV (DPP-IV) inhibitor.
|
| T68053 |
Denagliptin
|
483369-58-0
|
99.37%
|
|
|
Denagliptin is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor for the treatment of endocrine Ü metabolic diseases and can be used in the study of typ...
|
| T0242 |
Sitagliptin
|
486460-32-6
|
99.4%
|
|
|
Sitagliptin (MK0431), a new oral hypoglycemic (anti-diabetic drug), is a new dipeptidyl peptidase-4 (DPP-4) inhibitor. This enzyme-inhibiting drug is used either...
|
| T1581 |
Picolamine
|
3731-52-0
|
99.64%
|
|
|
Picolamine acts as a potential inhibitor of DPP-4.
|
| T15079 |
DBPR108
|
1186426-66-3
|
99.65%
|
|
|
DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.
|
| T0242L |
Sitagliptin phosphate monohydrate
|
654671-77-9
|
99.65%
|
|
|
Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts.
|
| T2316 |
Omarigliptin
|
1226781-44-7
|
99.70%
|
|
|
Omarigliptin (MK-3102) has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
|
